Skip to main
University-wide Navigation

Sanders-Brown Director Leads First Human Study of Drug Targeting Brain Inflammation

Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at UK, co-authored a paper reporting the first human clinical study of a drug candidate that suppresses injury and disease-induced inflammation of the brain.

Pilot Grant Funding for Studies on Alzheimer's Disease

The ADC is soliciting pilot grant applications focused on dynamic basic and clinical science studies of aging, AD, and related dementias. Each of the awards is intended to provide seed funding that will facilitate the initial testing of novel hypotheses that lead to national-level funding of an expanded research plan based on the pilot work.

UK Researcher Makes 'Top Science Stories of 2019' List by Discover Magazine

An international group of experts led by Dr. Peter Nelson, a neuropathologist at the UK Sanders-Brown Center on Aging, is being recognized as one of the top science stories of 2019 by Discover Magazine.

UK Honors Sanders-Brown Center on Aging Researchers

At UK's men's basketball game versus the University of Louisville on Dec. 28, UK Sanders-Brown Center on Aging Director Linda Van Eldik and researchers Pete Nelson, Donna Wilcock and Steve Scheff were recognized on the Rupp Arena floor.

Markesbery Scientific Symposium and Poster Session Set for Nov. 6

Guest speaker Adam Brickman, professor of Neuropsychology, Columbia University, as well as research updates from Sanders-Brown Center on Aging.

$2.8 Million Grant Will Fund Preclinical Study of New Dementia Treatment

The research is novel in that it is exploring efficacy in treating more than one form of dementia at the same time. 

Research Volunteers Drive Discoveries at Sanders-Brown Center on Aging

Thanks to volunteers, SBCoA has played a role in many landmark discoveries, including debunking the theories that aluminum or mercury cause Alzheimer's, identifying so-called "AD mimics", and proving that there are changes in the brain decades before there are outward symptoms of AD.

Behind the Blue: Sanders-Brown Director Linda Van Eldik Looks to the Future of Alzheimer's Research

In this episode of "Behind the Blue," Sanders-Brown director Linda Van Eldik talks about the center's involvement in some of the most important discoveries in the history of Alzheimer's research and what they are doing now to advance the science.

When is Alzheimer's Not Alzheimer's? Researchers Characterize a Different Form of Dementia

In the past, using "Alzheimer’s disease" & "dementia" interchangeably was a generally accepted practice. Now there's rising appreciation that a variety of diseases & disease processes contribute to dementia.

A Low Dose Aspirin for Dementia? Drug Ready for Human Testing

Linda Van Eldik, director of the UK Sanders-Brown Center on Aging, received $5.5 million from NIH and the Alzheimer's Drug Discovery Foundation. She developed a drug that is ready for its first round of testing in humans.